13, 14 and 21

/ NOV

LIVE FROM 8:00 AM TO 01PM

(UTC -3, SÃO PAULO, BRAZIL)

1st International Symposium on Minimal Treatment and Breast Imaging

Belo Horizonte   |   Minas Gerais   |   Brasil

MESSAGE FROM PRESIDENTS

Dear Colleagues,

We are pleased to invite you to the “BreastMit 2020 – Minimal Treatment and Breast Imaging Congress”, which will be held on November 13, 14, and 21, 2020. Due to the overwhelming response from sponsors, this conference is offered to you at No Cost!

BreastMit 2020 has top industry-leading experts eager to engage in current issues and discuss innovative techniques in minimal breast injury therapy. This virtual conference will be held via a state of the art digital event platform, easing the burden of travel. 

Streaming online, Breast Mit 2020 has expanded its agenda. Topics that will be discussed:

• Percutaneous treatment of initial tumors
• Selective omission of breast surgery after neoadjuvant chemotherapy
• Omission of neoadjuvant post-chemotherapy surgery
• Active surveillance for low-grade DCIS
• Contrasted mammography
• Magnetic resonance
• Artificial intelligence and more

International Speaker Spotlight

Henry M. Kuerer, MD, PhD, FACS- Executive Director, Breast Programs MD Anderson Cancer Network / United States
Ruud Pijnappel, MD, PhD, Prof.  Radiologist- Member of Board of Directors LRCB / Netherlands
Nisha Sharma, MBChB, BSB (Hons), MRCP, FRCR, MSC- Director of Breast Screening and
Clinical Lead for Breast Imaging / United Kingdom
Antonio Toesca, MD-  Breast Surgery European Institute of Oncology Milan / Italy
Alastair M. Thompson, ALCM, BSc(Hons), MBChB, MD, FRCSEd(Gen)- Olga Keith Wiess Chair of Surgery / United States); 
Stuart McIntosh, MD – Royal College of Surgeons Surgical Specialty Lead for Breast Surgery /United Kingdom.

The event will be free for members of the Brazilian Society of Mastology (SBM), the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Clinical Oncology (SBOC).
Minimal treatment and breast imaging have never been more important, don’t miss this opportunity to partake in this immeasurable live experience. 

We hope that you will join us! 

Henrique Lima Couto MD
Symposium President Head of Breast Image Department SBM

Vilmar Marques de Oliveira MD
Brazilian Society of Mastology President
(SBM)

Annamaria Massahud Rodrigues dos Santos
Brazilian Society of Mastology President – SBM
President – Regional

ORGANIZING COMMITTEE

Henrique Lima Couto

Annamaria Massahud Rodrigues dos Santos

Douglas de Miranda Pires

Jackeline Ribeiro Oliveira Guidoux

Cássio Furtini Haddad

Bertha Andrade Coelho

Cristóvão Pinheiro Barros

SCIENTIFIC COMMISSION

Annamaria Massahud Rodrigues dos Santos

Antonio Luiz Frasson

Fabio Postiglione Mansani

Felipe Eduardo Martins de Andrade

Francisco Pimentel Cavalcante

Henrique Lima Couto

Luiz Henrique Gebrim

Paula Cristina Saab

Rosemar Macedo Sousa Rahal

Ruffo de Freitas Junior

Thaís Paiva Moraes

Vilmar Marques de Oliveira

THE MAIN TOPICS ADDRESSED

SPEAKERS INTERNATIONAL GUESTS

Ruud Pijnappel

MD, PhD, Prof., Radiologist

Nisha Sharma

MBChB, BSB(Hons), MRCP, FRCR, MSC

Henry Mark Kuerer

MD, PhD, CMQ, FACS

Antonio Toesca

MD

Alastair M. Thompson

ALCM, BSc(Hons), MBChB, MD, FRCSEd(Gen)

Stuart McIntosh

MD

MAKE YOUR REGISTRATION FREE EVENT FOR DOCTORS

AND SBM MEMBERS
UNTIL
06/31/2020
UNTIL
08/31/2020
UNTIL
10/31/2020
FROM
11/01/2020
DOCTOR

All Specialties

Free Free Free Free
RESIDENT AND
GRADUATE STUDENT
All Specialties
Free Free Free Free
UNDERGRADUATE
STUDENT
R$ 100,00 R$ 125,00 R$ 150,00 R$ 200,00
OTHERS
PROFESSIONALS
R$ 450,00 R$ 500,00 R$ 550,00 R$ 600,00

PRELIMINARY PROGRAM - SUBJECT TO CHANGE SCIENTIFIC PROGRAM

08:00 - 08:05

OPENING

08:05 – 09:05

ROUND 1

DUCTAL CARCINOMA IN SITU (DCIS)

08:05 - 08:20:
Overdiagnosis and overtreatment – How big is the problem?

08:20 - 08:35:
Genetic signature for DCIS – Is it time for radiotherapy omission?

08:35 - 08:50:
Indolent lesions of Epithelial Origin (IDLE)

08:50 - 09:05:
Discussion

09:05 – 09:25

CONFERENCE

ADDRESSING OVERTREATMENT OF DCIS: WHAT TO DO NOW, WHAT TO DO IN THE FUTURE?

Speaker: Alastair M. Thompson (USA)

09:25 – 09:35

09:25 – 09:35:
Discussion

09:35 – 10:00

CONFERENCE

RESULTS AND APPLICATION OF CESM AS A BREAST IMAGING PROBLEM SOLVING TOOL AND IN EVALUATING PATIENTS FOR MINIMAL TREATMENT

Speaker: Ruud Pijnappel (Holland)

10:00 – 10:05

10:00 – 10:05:
Discussion

10:05 – 10:30

CONFERENCE

ADVANCED BREAST INTERVENTIONS

Speaker: Ruud Pijnappel (Holland)

10:30 – 10:35

10:30 – 10:35:
Discussion

10:35 – 11:00

CONFERENCE

DUCTAL CARCINOMA IN SITU AND ACTIVE SURVEILLANCE: RISKS, SECURITY, METHODS OF SAMPLE AND DIAGNOSIS

Speaker: Ruud Pijnappel (Holland)

11:00 – 11:05

11:00 – 11:05:
Discussion

11:05 – 13:00

ROUND 2

IMAGING

11:05 – 11:25:
Artificial intelligence for breast cancer screening, automated breast US, and the future of breast image

11:25 – 11:45:
Personalized breast cancer screening

11:45 – 12:05:
Breast cancer screening for high and intermediate risk patients

12:05 – 12:25:
Contrast enhanced spectral mammography (CESM) and MRI for prediction and evaluation of breast cancer response for neoadjuvant chemotherapy

12:25 – 12:45:
When is it possible to suspect tumor heterogeneity and repeat breast biopsy?

12:45 – 13:00:
Discussion

08:00 - 08:05

OPENING

08:05 – 09:00

ROUND 3

LESIONS OF UNCERTAIN MALIGNANT POTENTIAL (B3 LESIONS)

08:05 - 08:20:
Lesions of uncertain malignant potential (B3 lesions). Why is a simple core biopsy not enough for secure diagnose? Can immunohistochemistry substitute the complete excision of the lesion? Vacuum assisted biopsy (VAB) and vacuum assisted excision (VAE) pathological analyses and how i do it

08:20 - 08:35:
Imaging B3 lesions – Is it possible to select for VAB and VAE upfront?

08:35 - 08:50:
B3 lesions – VAE as the new gold standard – Is it reduces the diagnostic surgeries?

08:50 - 09:00:
Discussion

09:00 – 09:25

CONFERENCE

THE PRACTICAL ISSUES IN IMPLEMENTING CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) IN CLINICAL PRACTICE AND WHERE IS IT OF BENEFIT?

Speaker: Nisha Sharma (United Kingdom)

09:25 – 09:50

CONFERENCE

THE EXPANDING ROLE OF VAE FROM B3 LESIONS TO INVASIVE CANCERS

Speaker: Nisha Sharma (United Kingdom)

09:50 – 10:00

09:50 – 10:00:
Discussion

10:00 – 10:40

ROUND 4

SURGICAL MINIMAL TREATMENT FOR BREAST CANCER

10:00- 10:15:
Percutaneous treatment: resection technics - Where are we?

10:15 - 10:30:
Cryoablation – Where are we?

10:30 – 10:40:
Discussion

10:40 – 11:00

CONFERENCE

ROBOTIC SURGERY FOR BREAST CANCER – IS IT TIME TO PERFORM?

Speaker: Antonio Toesca (Italy)

11:00 – 11:10

11:00 – 11:10:
Discussion

11:10 – 11:25

CONFERENCE

VACUUM EXCISION OF T1 N0 BREAST CANCER – A BIG CHANGE FOR SMALL TUMOURS?

Speaker: Stuart Mcintosh (United Kingdom)

11:25 – 11:35

11:25 – 11:35:
Discussion

11:35 – 13:00

ROUND 5

NEW STANDARDS FOR BREAST CANCER TREATMENT

11:35 – 11:55:
Personalized and precision medicine: a new pattern for breast cancer treatment

11:55 – 12:20:
Rational use for prognostic genetic signature

12:20 – 12:35:
Genetic prognostic signatures for planning surgical treatment

12:35 – 12:50:
Liquid biopsy and breast cancer

12:50 – 13:00:
Discussion

08:00 - 08:05

OPENING

08:05 – 09:55

ROUND 6

-

08:05 - 08:20:
Evolution of systemic treatment and future perspectives

08:20 - 08:35:
Neoadjuvant chemotherapy as a new gold standard of treatment

08:35 - 08:50:
Pathological complete response and its meaning

08:50 - 09:05:
Breast image and molecular types of breast cancer – Is there reasonable correlation?

09:05 - 09:15:
Discussion

09:15 – 09:35

CONFERENCE

SURGERY AFTER NEOADJUVANT THERAPY: IS IT TIME TO CHANGE?

Speaker: Alastair M. Thompson (USA)

09:35 – 09:45

09:35 – 09:45:
Discussion

09:55 – 10:55

ROCHE SYMPOSIUM

10:55 – 11:15

CONFERENCE

EVALUATING PCR AFTER NST: IMAGING, CORE NEEDLE BIOPSY AND VACUUM BIOPSY - IS THERE SOMETHING YOU CAN RELY ON AND WHAT ARE THE CONSEQUENCES?

Speaker: Henry M. Kuerer (USA)

11:15 – 11:35

CONFERENCE

SELECTIVE OMISSION OF AXILLARY NODE DISSECTION FOR NODE POSITIVE BREAST CANCER AFTER NEOADJUVANT SYSTEMIC THERAPHY – IS IT POSSIBLE NOW OR IN NEAR FUTURE?

Speaker: Henry M. Kuerer (USA)

11:35 – 11:50

11:35 – 11:50:
Discussion

11:50 – 13:00

ROUND 7

SELECTIVE OMISSION OF AXILLARY SURGERY

11:50 – 12:10:
Sentinel node biopsy for luminal breast cancers after menopause, is it necessary?

12:10 – 12:30:
US and assisted minimally invasive diagnostic procedures for axilla – What are the available data?

12:30 – 12:50:
Tumor biology and axillary surgery: personalizing and de-escalating, is it possible?

12:50 – 13:00:
Discussion

LOCAL DO EVENTO

CENTRO DE CONVENÇÕES DA ASSOCIAÇÃO MÉDICA DE MINAS GERAIS

Avenida João Pinheiro, 161, Centro

Belo Horizonte – MG

Como chegar

DON'T MISS THE OPPORTUNITY Make your registration

SIGN UP FOR OUR NEWSLETTER

RECEIVE IN YOUR EMAIL ALL THE NEWS ABOUT THE EVENT

CIRURGIAS COMENTADAS POR Superespecialistas

REALIZATION

DIAMOND SPONSORSHIP

GOLD SPONSORSHIP

SPONSORSHIP

SUPPORT